Predicting benefit from imatinib: Are we close?

Mitul D. Gandhi; Virginia G. Kaklamani

doi:10.3109/10428194.2014.909041

Predicting benefit from imatinib: Are we close?

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	2421-2422
Number of pages	2
Journal	Leukemia and Lymphoma
Volume	55
Issue number	11
DOIs	https://doi.org/10.3109/10428194.2014.909041
State	Published - Nov 1 2014
Externally published	Yes

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.3109/10428194.2014.909041

Cite this

@article{d0ab1916d09a4e2ebbf7fa80c11a9a06,

title = "Predicting benefit from imatinib: Are we close?",

author = "Gandhi, {Mitul D.} and Kaklamani, {Virginia G.}",

year = "2014",

month = nov,

day = "1",

doi = "10.3109/10428194.2014.909041",

language = "English (US)",

volume = "55",

pages = "2421--2422",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "11",

}

TY - JOUR

T1 - Predicting benefit from imatinib

T2 - Are we close?

AU - Gandhi, Mitul D.

AU - Kaklamani, Virginia G.

PY - 2014/11/1

Y1 - 2014/11/1

UR - http://www.scopus.com/inward/record.url?scp=84912127521&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912127521&partnerID=8YFLogxK

U2 - 10.3109/10428194.2014.909041

DO - 10.3109/10428194.2014.909041

M3 - Comment/debate

C2 - 24684225

AN - SCOPUS:84912127521

SN - 1042-8194

VL - 55

SP - 2421

EP - 2422

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 11

ER -

Predicting benefit from imatinib: Are we close?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this